OR11K2P

Across TCGA pan-cancer cohorts, OR11K2P RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of OR11K2P’s most consistent transcriptional readouts.

The strongest signal is observed in prostate adenocarcinoma (PRAD), where OR11K2P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types OR11K2P is over-expressed in tumor.

PRAD and LUSC are the cancer types where OR11K2P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OR11K2P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
PRAD	All	All	+0.071	.026	2	view →
LUSC	Male	All	+0.007	.041	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

OR11K2P–PRAD

Open the PRAD breakdown →